Catalio co-founders George Petrocheilos and Jacob Vogelstein
After 45 investments in two years, Catalio reels in more funds to back 30 additional companies
Catalio Capital Management has seen a flurry of deal activity across its 45 portfolio companies in its nascent history, and the investor is ready to bankroll the next slate of drug developers, device makers, diagnostics creators and data companies with its third fund.
The New York, Baltimore and London investment shop picked up $381 million, nearly 4 times the size of its $100 million second fund and leaps and bounds bigger than its $15 million first fund when it launched in 2020.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
